stockrowMinerals Technologies Inc.
MTX Basic Materials Specialty Chemicals
Minerals Technologies Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.1 billion, down 2.17% from fiscal 2024.
- Revenue
- +4.23%
- EPS
- +2.80%
- Free cash flow
- +19.0%
- Total debt
- −0.67%
Quarter to September 2026, against a year earlier
Follow MTX
Alert me
Minerals Technologies Inc. (MTX) Revenue
Minerals Technologies Inc.'s revenue for fiscal 2025 was $2.1B, unchanged from fiscal 2024. Over the twelve months to 30 September 2026 it was $2.2B. Over the past ten years it has ranged from $1.6B (fiscal 2020) to $2.2B (fiscal 2023); the current reading is higher than 73% of that period. Minerals Technologies Inc. ranks 25th of 58 Specialty Chemicals companies by revenue.
Revenue, annual
Embed this chart
Annual newest first
| Period | Revenue | Change |
|---|---|---|
| FY2025 | $2.1B | (2.17%) |
| FY2024 | $2.1B | (2.37%) |
| FY2023 | $2.2B | 2.09% |
| FY2022 | $2.1B | 14.38% |
| FY2021 | $1.9B | 16.52% |
| FY2020 | $1.6B | (10.95%) |
| FY2019 | $1.8B | (0.92%) |
| FY2018 | $1.8B | 7.87% |
| FY2017 | $1.7B | 2.30% |
| FY2016 | $1.6B | (8.88%) |
Quarterly newest first
| Period | Revenue | Change |
|---|---|---|
| Sep 2026 | $554.9M | 1.19% |
| Jun 2026 | $548.4M | 0.27% |
| Mar 2026 | $546.9M | 5.27% |
| Dec 2025 | $519.5M | (2.42%) |
| 43 more quarters | Free account |
Against its own ten years
Revenue against peers
| Company | Revenue |
|---|---|
| CC The Chemours Company compare | $5.8B |
| FUL H. B. Fuller Company compare | $3.6B |
| SCL Stepan Company compare | $2.5B |
| MTX Minerals Technologies Inc. | $2.2B |
| KWR Quaker Houghton compare | $2.0B |
| IOSP Innospec Inc. compare | $1.9B |
| NGVT Ingevity Corporation compare | $1.2B |
| WDFC WD-40 Company compare | $688.0M |
| STDN Standard Nuclear Inc compare | — |
What Revenue is
Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.
Reported line item
More on MTX
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement